drug

VOMI

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by VA Office of Research and Development
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

1
Motivational Interviewing to Improve Work Outcomes in Schizophrenia
NCT00261716Phase 3Completed

KOLs & investigators

1
Shirley M. Glynn, PhDKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
VA Office of Research and Development
company
trial
Motivational Interviewing to Improve Work Outcomes in Schizophrenia
PHASE3
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
Schizoaffective Disorder
indication
KOL
Shirley M. Glynn, PhD
KOL score 5
person